Skip to content

Highly specific approach to reprogramming the immune system

About
Science
Platform
Team
News

Home

Search for:

Recent Posts

MorphImmune, Inc. Appoints Ronald Martell as President and CEO
Targeted therapies developed to reduce lung fibrosis
Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Recent Comments

[image src="https://themes.muffingroup.com/be/charity3/wp-content/uploads/2020/04/ngo2.png" align="center"] [divider height="20"]

Lorem ipsum dolor sit amet enim. Etiam ullamcorper. Suspendisse a pellentesque dui, non felis. Maecenas malesuada elit lectus felis, malesuada ultricies. Curabitur et ligula. Ut molestie a, ultricies porta urna.

MorphImmune, Proudly powered by WordPress.

Lorem ipsum
Quisque
Integer

Connect With Us

Do you have any questions or just want to connect? We would love to hear from you.

Name

Email

Message